MMVV

MMVV refers to the Marburgvirus disease, a rare and severe illness in humans and nonhuman primates caused by infection with the Marburg virus. The virus is a filovirus, belonging to the same family as the Ebola virus, and is known for causing hemorrhagic fever. The initial outbreak occurred in 1967 in Marburg and Frankfurt, Germany, and in Belgrade, Serbia, linked to infected monkeys imported from Uganda.

Transmission to humans is thought to occur through direct contact with infected animals, such as fruit bats or monkeys, or through direct contact with the blood, body fluids, and tissues of infected people. Symptoms typically appear abruptly, including high fever, severe headache, muscle aches, and malaise. Over time, these can progress to diarrhea, vomiting, abdominal pain, and unexplained hemorrhages.

There is no specific antiviral treatment or vaccine approved for Marburg virus disease. Treatment focuses on supportive care, such as rehydration and treatment of symptoms. The fatality rate can be high, with past outbreaks reporting rates ranging from 24% to 88%. Prevention strategies include avoiding contact with infected animals and implementing strict infection control measures in healthcare settings.